Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments

• Main Authors: Flaminia Coluzzi, Monica Rocco, Rula Green Gladden, Pietro Persiani, Laurel A. Thur, Filippo Milano
• Format: Article
• Language: English
• Published: MDPI AG 2020-12-01
• Series: Cancers
• Subjects: leukemia; children; opioids; osteonecrosis; chronic pain; neuropathic pain
• Online Access: https://www.mdpi.com/2072-6694/12/12/3671

Pain is one of the most common symptoms in children suffering from leukemia, who are often misdiagnosed with other childhood painful diseases such as juvenile idiopathic arthritis. Corticosteroid-induced osteonecrosis (ON) and vincristine-induced peripheral neuropathy (VIPN) are the most common painful manifestations. Additionally, ongoing pain may continue to impact quality of life in survivorship. This narrative review focuses on the pathophysiological mechanisms of pain in childhood leukemia and current available indications for analgesic treatments. Pain management in children is often inadequate because of difficulties in pain assessment, different indications across countries, and the lack of specific pediatric trials. Analgesic drugs are often prescribed off-label to children by extrapolating information from adult guidelines, with possible increased risk of adverse events. Optimal pain management should involve a multidisciplinary team to ensure assessment and interventions tailored to the individual patient.